Molecular mechanisms by which dietary isoflavones potentially prevent atherosclerosis

Expert Reviews in Molecular Medicine

Volumn 5, Issue 24, 2003, Pages

  Cassidy, Aedin ^a   De Pascual Teresa, Sonia ^b   Rimbach, Gerald ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b INSTITUTO DEL FRÍO CSIC   (Spain)

Author keywords

antioxidant; arteriosclerosis; atherosclerosis; daidzein; geinstein; isoflavone; phytoestrogen; soya

Indexed keywords

ESTROGEN RECEPTOR; ISOFLAVONE DERIVATIVE; LIPID; PHYTOESTROGEN;

ANIMAL; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIET; FEMALE; GENETICS; HUMAN; MALE; PHYSIOLOGY; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; ATHEROSCLEROSIS; CORONARY DISEASE; DIET; FEMALE; HUMANS; ISOFLAVONES; LIPIDS; MALE; PHYTOESTROGENS; RECEPTORS, ESTROGEN; TISSUE DISTRIBUTION;

EID: 84867552819     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399403006732     Document Type: Review

References (93)

1. Setchell, K.D. and Cassidy, A. (1999) Dietary isoflavones: biological effects and relevance to human health. J Nutr 129, 758S-767S, PubMed: 10082786
2. Cassidy, A. and Faughnan, M. (2000) Phyto-oestrogens through the life cycle. Proc Nutr Soc 59, 489-496, PubMed: 10997682
3. Bingham, M. et al. (2003) Gut metabolism and cardioprotective effects of dietary isoflavones. Curr Topics Nutraceutical Res 1, 31-48
4. Setchell, K.D. et al. (1981) Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet 2, 4-8, PubMed: 6113409
5. Thompson, L.U. et al. (1991) Mammalian lignan production from various foods. Nutr Cancer 16, 43-52, PubMed: 1656395
6. Brzozowski, A.M. et al. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758, PubMed: 9338790 (Pubitemid 27458965)
7. Setchell, K.D. et al. (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131, 1362S-1375S, PubMed: 11285356 (Pubitemid 32268489)
8. Setchell, K.D. et al. (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 40, 569-578, PubMed: 6383008 (Pubitemid 14035518)
9. Cassidy, A., Bingham, S. and Setchell, K.D. (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60, 333-340, PubMed: 8074062 (Pubitemid 24278733)
10. Setchell, K.D. et al. (2003) Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77, 411-419, PubMed: 12540402 (Pubitemid 36133385)
11. Bennets, H.W., Underwood, E.J. and Shier, F.L. (1946) A specific breeding problem of sheep in subterranean clover pastures in western Australia. Australian Veterinary Journal 22, 2-12
12. Miksicek, R.J. (1994) Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49, 153-160, PubMed: 8031711 (Pubitemid 24237089)
13. Kuiper, G.G. et al. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863-870, PubMed: 9048584 (Pubitemid 27089735)
14. Kuiper, G.G. et al. (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93, 5925-5930, PubMed: 8650195 (Pubitemid 26190778)
15. Kuiper, G.G. et al. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263, PubMed: 9751507 (Pubitemid 28513713)
16. Setchell, K.D. (2001) Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20, 354S-362S; discussion 381S-383S, PubMed: 11603644 (Pubitemid 32948014)
17. Adlercreutz, H., Markkanen, H. and Watanabe, S. (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210, PubMed: 7901532 (Pubitemid 23331713)
18. Zhang, Y. et al. (1999) Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J Nutr 129, 399-405, PubMed: 10024618 (Pubitemid 29072127)
19. Wei, H. et al. (1993) Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20, 1-12, PubMed: 8415125 (Pubitemid 23225362)
20. Guo, Q. et al. (2002) ESR and cell culture studies on free radical-scavenging and antioxidant activities of isoflavonoids. Toxicology 179, 171-180, PubMed: 12204553 (Pubitemid 35245473)
21. Rimbach, G. et al. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica (in press)
22. Arora, A., Nair, M.G. and Strasburg, G.M. (1998) Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 356, 133-141, PubMed: 9705203 (Pubitemid 28387717)
23. Mitchell, J.H. et al. (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 360, 142-148, PubMed: 9826439 (Pubitemid 29010923)
24. Tikkanen, M.J. et al. (1998) Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 95, 3106-3110, PubMed: 9501223 (Pubitemid 28135862)
25. Kapiotis, S. et al. (1997) Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 17, 2868-2874, PubMed: 9409268 (Pubitemid 28016034)
26. Poulter, N. (1999) Coronary heart disease is a multifactorial disease. Am J Hypertens 12, 92S-95S, PubMed: 10555607 (Pubitemid 29528689)
27. Badimon, L. (2001) New challenges in the etiopathogenesis of atherothrombosis. Cerebrovasc Dis 11 Suppl 1, 80-84, PubMed: 11244204
28. Collins, T. and Cybulsky, M.I. (2001) NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107, 255-264, PubMed: 11160146 (Pubitemid 32157955)
29. Cassidy, A. and Griffin, B. (1999) Phyto-oestrogens: a potential role in the prevention of CHD? Proc Nutr Soc 58, 193-199, PubMed: 10343357 (Pubitemid 29225564)
30. Anderson, J.W., Johnstone, B.M. and Cook-Newell, M.E. (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276-282, PubMed: 7596371
31. Sirtori, C.R., Even, R. and Lovati, M.R. (1993) Soybean protein diet and plasma cholesterol: from therapy to molecular mechanisms. Ann N Y Acad Sci 676, 188-201, PubMed: 8489131 (Pubitemid 23158859)
32. Tovar-Palacio, C. et al. (1998) Intake of soy protein and soy protein extracts influences lipid metabolism and hepatic gene expression in gerbils. J Nutr 128, 839-842, PubMed: 9566990 (Pubitemid 28225513)
33. Kirk, E.A. et al. (1998) Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 128, 954-959, PubMed: 9614153 (Pubitemid 28280193)
34. Anthony, M.S. et al. (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126, 43-50, PubMed: 8558324 (Pubitemid 26030632)
35. Anthony, M.S. (1998) Comparison of soy phytoestrogens and conjugated equine estrogens on atherosclerosis progression in post-menopausal monkeys. Circulation 97, 829 (abstract)
36. Anthony, M.S., Clarkson, T.B. and Williams, J.K. (1998) Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr 68, 1390S-1393S, PubMed: 9848505 (Pubitemid 28550918)
37. Cassidy, A., Bingham, S. and Setchell, K. (1995) Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr 74, 587-601, PubMed: 7577895
38. Nagata, C. et al. (1998) Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 128, 209-213, PubMed: 9446845 (Pubitemid 28124988)
39. Crouse, J.R., 3rd et al. (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159, 2070-2076, PubMed: 10510993
40. Nestel, P.J. et al. (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 17, 3392-3398, PubMed: 9437184 (Pubitemid 28028547)
41. Hodgson, J.M. et al. (1998) Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr 128, 728-732, PubMed: 9521635 (Pubitemid 28158487)
42. Nestel, P.J. et al. (1999) Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 84, 895-898, PubMed: 10084567 (Pubitemid 29138214)
43. Baum, J.A. et al. (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68, 545-551, PubMed: 9734729 (Pubitemid 28402375)
44. Cherry, N. et al. (2002) Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet 360, 2001-2008, PubMed: 12504395 (Pubitemid 36026578)
45. Potter, S.M. (1998) Soy protein and cardiovascular disease: the impact of bioactive components in soy. Nutr Rev 56, 231-235, PubMed: 9735676 (Pubitemid 28419770)
46. Register, T.C. and Adams, M.R. (1998) Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J Steroid Biochem Mol Biol 64, 187-191, PubMed: 9605413 (Pubitemid 28200991)
47. Chen, C.C., Wang, J.K. and Lin, S.B. (1998) Antisense oligonucleotides targeting protein kinase C-alpha,-beta I, or-delta but not-eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism. J Immunol 161, 6206-6214, PubMed: 9834107
48. Zhu, Y. et al. (2002) Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295, 505-508, PubMed: 11799247 (Pubitemid 34101642)
49. Honore, E.K. et al. (1997) Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 67, 148-154, PubMed: 8986700 (Pubitemid 26428429)
50. Williams, J.K. and Clarkson, T.B. (1998) Dietary soy isoflavones inhibit in-vivo constrictor responses of coronary arteries to collagen-induced platelet activation. Coron Artery Dis 9, 759-764, PubMed: 9919424 (Pubitemid 29012188)
51. Washburn, S. et al. (1999) Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6, 7-13, PubMed: 10100174 (Pubitemid 29131753)
52. Cybulsky, M.I. and Gimbrone, M.A., Jr. (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791, PubMed: 1990440
53. Thiery, J. et al. (1996) Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. Atherosclerosis 121, 63-73, PubMed: 8678925 (Pubitemid 26072703)
54. Rimbach, G. et al. (2000) Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun 3, 238-242, PubMed: 10891398 (Pubitemid 30602030)
55. Rubanyi, G.M. (1993) The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22 Suppl 4, S1-14, PubMed: 7523767
56. Baeuerle, P.A. and Henkel, T. (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12, 141-179, PubMed: 8011280
57. Kunsch, C. and Medford, R.M. (1999) Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85, 753-766, PubMed: 10521248 (Pubitemid 29480816)
58. Saliou, C., Valacchi, G. and Rimbach, G. (2001) Assessing bioflavonoids as regulators of NF-kappa B activity and inflammatory gene expression in mammalian cells. Methods Enzymol 335, 380-387, PubMed: 11400387 (Pubitemid 32507255)
59. Brand, K. et al. (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97, 1715-1722, PubMed: 8601637 (Pubitemid 26105480)
60. Lindner, V. and Collins, T. (1996) Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model. Am J Pathol 148, 427-438, PubMed: 8579106 (Pubitemid 26056728)
61. Brand, K. et al. (1997) Role of nuclear factor-kappa B in atherogenesis. Exp Physiol 82, 297-304, PubMed: 9129944
62. Yan, S.D. et al. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269, 9889-9897, PubMed: 8144582 (Pubitemid 24196599)
63. Shames, B.D. et al. (1999) LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent. J Surg Res 83, 69-74, PubMed: 10210645 (Pubitemid 29394109)
64. Barnes, S. et al. (2000) Isoflavonoids and chronic disease: mechanisms of action. Biofactors 12, 209-215, PubMed: 11216488 (Pubitemid 32107408)
65. Davis, J.N. et al. (2001) Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes. Free Radic Biol Med 30, 1293-1302, PubMed: 11368927 (Pubitemid 32463940)
66. May, M.J., Wheeler-Jones, C.P. and Pearson, J.D. (1996) Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells. Br J Pharmacol 118, 1761-1771, PubMed: 8842442 (Pubitemid 26252672)
67. Weber, C. et al. (1995) Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 155, 445-451, PubMed: 7541425
68. McGregor, P.E., Agrawal, D.K. and Edwards, J.D. (1994) Attenuation of human leukocyte adherence to endothelial cell monolayers by tyrosine kinase inhibitors. Biochem Biophys Res Commun 198, 359-365, PubMed: 8292041 (Pubitemid 24172761)
69. Tedesco, F. et al. (1999) Complement-endothelial cell interactions: pathophysiological implications. Mol Immunol 36, 261-268, PubMed: 10403479 (Pubitemid 29281854)
70. Moncada, S., Palmer, R.M. and Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109-142, PubMed: 1852778
71. Ignarro, L.J. (1994) Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins. Adv Pharmacol 26, 35-65, PubMed: 7913618
72. Beckman, J.S. and Koppenol, W.H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271, C1424-1437, PubMed: 8944624
73. Stuehr, D.J. and Marletta, M.A. (1987) Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J Immunol 139, 518-525, PubMed: 3110273 (Pubitemid 17104054)
74. Narumi, S., Finke, J.H. and Hamilton, T.A. (1990) Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J Biol Chem 265, 7036-7041, PubMed: 2108965
75. Tetsuka, T. and Morrison, A.R. (1995) Tyrosine kinase activation is necessary for inducible nitric oxide synthase expression by interleukin-1 beta. Am J Physiol 269, C55-59, PubMed: 7543244
76. Li, W., Xia, J. and Sun, G.Y. (1999) Cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC): response to genistein and pyrrolidine dithiocarbamate. J Interferon Cytokine Res 19, 121-127, PubMed: 10090397 (Pubitemid 29109628)
77. Gottstein, N. et al. (2003) Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Br J Nutr 89, 607-616, PubMed: 12720581
78. Azumi, S., Tanimura, A. and Tanamoto, K. (1997) A novel inhibitor of bacterial endotoxin derived from cinnamon bark. Biochem Biophys Res Commun 234, 506-510, PubMed: 9177302 (Pubitemid 27243934)
79. Sheu, F., Lai, H.H. and Yen, G.C. (2001) Suppression effect of soy isoflavones on nitric oxide production in RAW 264.7 macrophages. J Agric Food Chem 49, 1767-1772, PubMed: 11308324 (Pubitemid 32816817)
80. Green, S.J. et al. (1990) Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol 145, 4290-4297, PubMed: 2124240
81. Jun, C.D. et al. (1995) Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages. J Immunol 154, 6541-6547, PubMed: 7759887
82. Nelken, N.A. et al. (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88, 1121-1127, PubMed: 1843454
83. Yla-Herttuala, S. et al. (1991) Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88, 5252-5256, PubMed: 2052604 (Pubitemid 21914722)
84. Boring, L. et al. (1998) Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897, PubMed: 9732872 (Pubitemid 28410911)
85. Peluso, M.R. et al. (2000) A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J Nutr 130, 2333-2342, PubMed: 10958832
86. Nakashima, S., Koike, T. and Nozawa, Y. (1991) Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Mol Pharmacol 39, 475-480, PubMed: 2017148
87. Beretz, A. et al. (1982) Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. Biochem Pharmacol 31, 3597-3600, PubMed: 6295405 (Pubitemid 13244124)
88. Landolfi, R., Mower, R.L. and Steiner, M. (1984) Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem Pharmacol 33, 1525-1530, PubMed: 6329230 (Pubitemid 14105028)
89. Packham, M.A. and Mustard, J.F. (1977) Clinical pharmacology of platelets. Blood 50, 555-573, PubMed: 332253 (Pubitemid 8194882)
90. Pignatelli, P. et al. (1998) Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 91, 484-490, PubMed: 9427701 (Pubitemid 28053370)
91. Iuliano, L. et al. (1994) Role of hydroxyl radicals in the activation of human platelets. Eur J Biochem 221, 695-704, PubMed: 8174549 (Pubitemid 24128039)
92. Ruiz-Larrea, M.B. et al. (1997) Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 26, 63-70, PubMed: 9018473 (Pubitemid 27060130)
93. Wei, H. et al. (1995) Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208, 124-130, PubMed: 7892286